Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Atterx BioTherapeutics, Inc. logo — company profile

Atterx BioTherapeutics, Inc.

Founded 2001 4 employees Series C Total: $6.20M Biopharma, Biotechnology +1

General Information

Company Name Atterx BioTherapeutics, Inc.
Founded Year 2001
Employees 4
Industries Biopharma, Biotechnology, Health and Wellness
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with Atterx BioTherapeutics, Inc.. To contact Atterx BioTherapeutics, Inc., visit atterx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Atterx BioTherapeutics, Inc.

Atterx BioTherapeutics, Inc. is a biopharmaceutical company founded in 2001 which focuses on developing proprietary products for the prevention and treatment of multi-drug resistant Gram negative bacterial infections. The company operates in the Biopharma and Biotechnology industries. Atterx BioTherapeutics recently received a Series C investment on 17 January 2023, with Michigan Rise being the lead investors. This funding round signifies a significant milestone for the company as it continues to advance its innovative products in the fight against antibiotic-resistant bacterial infections.

Taxonomy: proprietary products, prevention, treatment, multi-drug resistant, Gram negative, bacterial infections

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series C Undisclosed 1
Michigan Rise
Michigan Rise
17 Jan 2023
Venture Round $375.00K -
22 Apr 2016
Convertible Note $595.00K -
06 Dec 2013
Venture Round $1.93M 1
Wisconsin Investment Partners
Wisconsin Investment Partners
10 May 2010
Venture Round $3.30M 2
Wisconsin Investment Partners Rosetta Partners
Wisconsin Investment Partners, Rosetta Partners
13 Dec 2006

Atterx BioTherapeutics, Inc. Alternatives & Competitors

Atterx BioTherapeutics, Inc. vs
Biocidium Biopharmaceuticals
Biocidium Biopharmaceuticals Canada

Clinical-stage biopharmaceutical company focused on novel antibiotics, antifungals, and treatments f...

1 employees
Biopharma, Biotechnology
Atterx BioTherapeutics, Inc. vs
Prokaryotics, Inc.
Prokaryotics, Inc. United States

Antibacterial discovery organization committed to bringing forth innovative therapeutics to address...

8 employees
Biopharma, Biotechnology
Atterx BioTherapeutics, Inc. vs
Adaptive Phage Therapeutics
Adaptive Phage Therapeutics United States

To save lives or restore health as a leader in safe, rapidly deployable, cost-effective cures for ba...

Acquired
28 employees
Biotechnology, Health Care

FAQ About Atterx BioTherapeutics, Inc.

Proprietary products for the prevention and treatment of multi-drug resistant Gram negative bacterial infections.
Atterx BioTherapeutics, Inc. was founded in 2001.
Atterx BioTherapeutics, Inc. operates in Biopharma, Biotechnology and Health and Wellness. Its work centres on proprietary products, prevention, treatment and multi-drug resistant.
Atterx BioTherapeutics, Inc. has approximately 4 employees.
Atterx BioTherapeutics, Inc. has completed 5 funding rounds, raising a total of $6.20M. The latest funding stage is Series C.
Top alternatives and competitors to Atterx BioTherapeutics, Inc. include Biocidium Biopharmaceuticals, Prokaryotics, Inc., Adaptive Phage Therapeutics, Techulon Inc., OM Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Atterx BioTherapeutics, Inc. and Biocidium Biopharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Atterx BioTherapeutics, Inc., https://bouncewatch.com/company/atterx-biotherapeutics-inc, updated 12 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes